The bitter and astringent tasting Pashanbhed has light and unctuous qualities, cold potency, and bitter post-digestive taste.

Thailand: Use of sodium-glucose co-transporter-2 inhibitors (SGLT2is) may help reduce the risk of kidney stone formation in ...

TUESDAY, Nov. 12, 2024 (HealthDay News) -- For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in recurrence, according to a study ...

Patanjali Divya Lithom Tablet presents a compelling Ayurvedic support option for individuals concerned with kidney stone ...

The prevalence of nephrolithiasis has been increasing in recent years, affecting appro­ximately 10% and 15% of the population. Kidney stone disease is associated with syste­mic comorbidities such as ...

This insightful review examines drug-associated nephrolithiasis using the VigiBase pharmacovigilance database, identifying medications (some previously unrecognised) linked to kidney stone formation.

Kidney stones, also known as nephrolithiasis or urolithiasis, are prevalent worldwide. In India, the incidence is about 12-13%. Recurrence: Around 50% of patients experience a recurrence within five ...

Compared with DPP4 inhibitors, SGLT2 inhibitors reduce the risk for kidney and ureteral stones in patients with type 2 diabetes, including those with a stone history. Sodium-glucose cotransporter 2 ...

Study of 2.4 million participants reveals potential advantages for cardiometabolic and psychiatric conditions alongside increased risks of gastrointestinal and musculoskeletal issues Study: Mapping ...

Anyone who's ever had a kidney stone will tell you there's nothing else like the mind-numbing, excruciating pain. Sometimes a patient will have a single stone and then never have a recurrence. Other ...